Company intelligence / Profile preview

Noshaq

Liège, Wallonia, Belgium

Ownership: Private
Employees: ~54
Development stage: Other

Overview

Noshaq is not a life science R&D company but a Liège-headquartered investment fund (formerly Meusinvest) specializing in supporting the creation and growth of companies, including in the biotech, pharma, and healthtech sectors. It does not develop drugs itself but is a minority investor in biotech and pharma companies, maintaining a diverse investment portfolio and taking an active role in developing the regional healthcare and life science ecosystem[1][4][5][8].

Industry: Investors

Partnerships

University of LiègeVarious regional and international funds/incubators (e.g., IMEC, Flemish biotech funds)[1][4]

Beyond the preview

Go deeper on Noshaq.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Noshaq.

Explore the full profile